Journal Article

Hydroxychloroquine dose tapering or discontinuation in cutaneous lupus erythematosus after remission: A retrospective multicenter cohort study of 56 patients

Journal of the American Academy of Dermatology (2022) 87(1) 203-206
DOI: 10.1016/j.jaad.2021.07.038
6Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Author supplied keywords

Cite

CITATION STYLE

APA

Sonigo, G., Jachiet, M., Bessis, D., Cordel, N., Faucon, C., Petit, A., … Chasset, F. (2022). Hydroxychloroquine dose tapering or discontinuation in cutaneous lupus erythematosus after remission: A retrospective multicenter cohort study of 56 patients. Journal of the American Academy of Dermatology, 87(1), 203–206. https://doi.org/10.1016/j.jaad.2021.07.038

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free